Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality.

Published

Journal Article

To examine the relationships among the variable number of tandem repeats in the monoamine oxidase-A linked polymorphic region allelic variation (MAOA-uVNTR) and the symptoms of depression and sleep quality. The monoamine oxidase-A (MAOA) gene, which plays a vital role in degradation of neurotransmitters such as serotonin, norepinephrine, and dopamine, contains a polymorphism in its promoter region (MAOA-uVNTR) that affects transcriptional efficiency. MAOA-uVNTR genotype has been associated with both psychological and physical measures.The sample consisted of 74 males enrolled in a case/control study of caregivers for relatives with dementia. Age- and race-adjusted linear regression models were used to examine the association between low versus high MAOA-uVNTR activity alleles, symptoms of depression (Center for Epidemiological Studies of Depression), and sleep quality ratings (Pittsburgh Sleep Quality Index).MAOA-uVNTR alleles associated with less transcriptional activity were related to increased symptoms of depression (p < .04; Cohen's d = 0.52) and poorer sleep quality (p < .04; Cohen's d = 0.31).Individuals with less active MAOA-uVNTR alleles may be at increased risk for depressive symptoms and poor sleep.

Full Text

Duke Authors

Cited Authors

  • Brummett, BH; Krystal, AD; Siegler, IC; Kuhn, C; Surwit, RS; Züchner, S; Ashley-Koch, A; Barefoot, JC; Williams, RB

Published Date

  • June 2007

Published In

Volume / Issue

  • 69 / 5

Start / End Page

  • 396 - 401

PubMed ID

  • 17585061

Pubmed Central ID

  • 17585061

Electronic International Standard Serial Number (EISSN)

  • 1534-7796

International Standard Serial Number (ISSN)

  • 0033-3174

Digital Object Identifier (DOI)

  • 10.1097/psy.0b013e31806d040b

Language

  • eng